IT8222761A0 - Esteri piridincarbossilici della dopamina e suoi alchie derivati - Google Patents

Esteri piridincarbossilici della dopamina e suoi alchie derivati

Info

Publication number
IT8222761A0
IT8222761A0 IT8222761A IT2276182A IT8222761A0 IT 8222761 A0 IT8222761 A0 IT 8222761A0 IT 8222761 A IT8222761 A IT 8222761A IT 2276182 A IT2276182 A IT 2276182A IT 8222761 A0 IT8222761 A0 IT 8222761A0
Authority
IT
Italy
Prior art keywords
alkye
dopamine
derivatives
carboxyl esters
pyridine carboxyl
Prior art date
Application number
IT8222761A
Other languages
English (en)
Other versions
IT1210918B (it
Inventor
Cesare Casagrande
Emilio Mussini
Vittorio Vecchietti
Original Assignee
Simes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes filed Critical Simes
Publication of IT8222761A0 publication Critical patent/IT8222761A0/it
Priority to IT8222761A priority Critical patent/IT1210918B/it
Priority to EP83201138A priority patent/EP0101633B1/en
Priority to DE8383201138T priority patent/DE3368051D1/de
Priority to AT83201138T priority patent/ATE23996T1/de
Priority to IE1839/83A priority patent/IE55647B1/en
Priority to AU17564/83A priority patent/AU1756483A/en
Priority to ZA835743A priority patent/ZA835743B/xx
Priority to CA000433946A priority patent/CA1234572A/en
Priority to ES525464A priority patent/ES525464A0/es
Priority to DK358283A priority patent/DK358283A/da
Priority to JP58144334A priority patent/JPS5962570A/ja
Priority to US06/699,598 priority patent/US4644004A/en
Application granted granted Critical
Publication of IT1210918B publication Critical patent/IT1210918B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IT8222761A 1982-08-06 1982-08-06 Esteri piridincarbossilici della dopamina e suoi alchie derivati IT1210918B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT8222761A IT1210918B (it) 1982-08-06 1982-08-06 Esteri piridincarbossilici della dopamina e suoi alchie derivati
EP83201138A EP0101633B1 (en) 1982-08-06 1983-08-01 Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
DE8383201138T DE3368051D1 (en) 1982-08-06 1983-08-01 Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
AT83201138T ATE23996T1 (de) 1982-08-06 1983-08-01 Pyridincarboxylsaeureester von dopamin und seinen n-alkyl-derivaten.
IE1839/83A IE55647B1 (en) 1982-08-06 1983-08-03 Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
AU17564/83A AU1756483A (en) 1982-08-06 1983-08-03 Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
ZA835743A ZA835743B (en) 1982-08-06 1983-08-04 Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
CA000433946A CA1234572A (en) 1982-08-06 1983-08-05 Process for preparing pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
ES525464A ES525464A0 (es) 1982-08-06 1983-08-05 Procedimiento para la preparacion de esteres piridincarboxilicos de dipamina y de sus derivados n-alquilicos.
DK358283A DK358283A (da) 1982-08-06 1983-08-05 Fremgangsmaade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf
JP58144334A JPS5962570A (ja) 1982-08-06 1983-08-06 ドパミンならびにそのｎ−アルキル誘導体のピリジンカルボン酸エステル
US06/699,598 US4644004A (en) 1982-08-06 1985-02-08 Pyridynecarboxylic esters of dopamine and of its N-alkyl derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8222761A IT1210918B (it) 1982-08-06 1982-08-06 Esteri piridincarbossilici della dopamina e suoi alchie derivati

Publications (2)

Publication Number Publication Date
IT8222761A0 true IT8222761A0 (it) 1982-08-06
IT1210918B IT1210918B (it) 1989-09-29

Family

ID=11200146

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8222761A IT1210918B (it) 1982-08-06 1982-08-06 Esteri piridincarbossilici della dopamina e suoi alchie derivati

Country Status (12)

Country Link
US (1) US4644004A (it)
EP (1) EP0101633B1 (it)
JP (1) JPS5962570A (it)
AT (1) ATE23996T1 (it)
AU (1) AU1756483A (it)
CA (1) CA1234572A (it)
DE (1) DE3368051D1 (it)
DK (1) DK358283A (it)
ES (1) ES525464A0 (it)
IE (1) IE55647B1 (it)
IT (1) IT1210918B (it)
ZA (1) ZA835743B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660141B2 (ja) * 1989-09-12 1994-08-10 三井東圧化学株式会社 ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2428253A (en) * 1940-03-23 1947-09-30 Werder Fritz Von Water-soluble derivatives of 2-methyl-1, 4-dihydroxy-naphthalene and processes for their production
US3904671A (en) * 1969-04-01 1975-09-09 Sterling Drug Inc Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones

Also Published As

Publication number Publication date
DK358283A (da) 1984-02-07
US4644004A (en) 1987-02-17
JPS5962570A (ja) 1984-04-10
CA1234572A (en) 1988-03-29
EP0101633B1 (en) 1986-12-03
AU1756483A (en) 1984-02-09
DK358283D0 (da) 1983-08-05
IE55647B1 (en) 1990-12-05
JPH0434541B2 (it) 1992-06-08
ES8502972A1 (es) 1985-02-01
IT1210918B (it) 1989-09-29
EP0101633A1 (en) 1984-02-29
DE3368051D1 (en) 1987-01-15
ES525464A0 (es) 1985-02-01
ZA835743B (en) 1984-06-27
IE831839L (en) 1984-02-06
ATE23996T1 (de) 1986-12-15

Similar Documents

Publication Publication Date Title
IT1111631B (it) Dispositivo per l ispezione ed il controllo di oggetti trasparenti
IT1092895B (it) Generatore di segnali di indirizzo e di interruzione
IT1097833B (it) Acidi imidazolcarbossilici e loro derivati
IT1074038B (it) Esteri della epinina
IT1106176B (it) Derivati di pirrolo loro procedimento di preparazione e loro applicazione terapeutica
IT8168585A0 (it) Derivati della 2 ossoazetidina loro produzione ed impiego
IT1212882B (it) Derivati basici della cumarina
IT1102755B (it) Derivati di feptidi e loro preparazione
IT7849859A0 (it) Derivati di 2-benzoil-4-cloro-glici nanilidi sostituite loro procedimento di preparazione e loro applicazione terapeutica
IT1110097B (it) Derivati della cumarina
IT1192621B (it) Derivati della maleinimmide e succinimmide e procedimento per la loro preparazione
ITPD910160A1 (it) Esteri di derivati carbossilici di polisaccaridi
DK387182A (da) (+)-4-substitueret-2-indanoler og insekticide esterderivater
IT1170641B (it) Derivati della bis-moranolina
IT7849127A0 (it) Acido cicloesancarbossilico e suoi derivati
IT8822760A0 (it) Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali
IT8222761A0 (it) Esteri piridincarbossilici della dopamina e suoi alchie derivati
IT7850879A0 (it) Derivati 25-alchilcolesterolici erelativo procedimento di produzione
IT1120985B (it) Derivati della piperidina e procedimento per la loro preparazione
IT7852471A0 (it) Derivati di 2-amminometil-fenolo eprocedimento per la loro preparazione
PL201539A1 (pl) Sposob wytwarzania maytansinolu i jego pochodnych
SE7605298L (sv) Apparat for avskalning och hopkoppling av samhorande tradar i tradpar
IT7825800A0 (it) Procedimento per la fabbricazione di p-idrossifenilglicina e suoi derivati
IT1147079B (it) Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT8249205A0 (it) Derivati di estere idolacetico eprocedimento per prepararli